Healthcare

The study looked at 82,662 people each year with bowel symptoms who are referred to public hospitals. It modelled the effect of GPs using ColoSTAT before referring patients for colonoscopy.

Cohort 2 is testing whether the infusion period can be reduced from 140 minutes, as used in Cohort 1, to 60 minutes. The cohort is fully recruited with six patients enrolled, and topline results are expected by the end of 2026.

The second batch provides enough product to complete dose escalation and begin dose expansion in the trial. A third batch is expected before the end of the year and is anticipated to supply the material needed to complete the Phase 1 study.

The study targeted Ixodes scapularis, commonly known as the deer tick or blacklegged tick. This species transmits 7 of the 19 tick-borne pathogens recorded in the United States and is a major vector of Lyme disease.

CurveBeam AI Limited listed on the ASX on 23 August 2023 and is classified in the Health Care sector, within health care equipment and services. The ASX describes it as developing,Manufacturingand selling specialised medical imaging scanners and software.

Cochlear makes cochlear implant systems and related sound processors, and it earnsRecurring Revenuefrom upgrading and servicing them. FY26 sales revenue was A$2,343.4 million, up 2 per cent in constant currency.

EXO-OC had shown promise in an earlier retrospective study of 498 samples, which reported 92.5 per cent sensitivity across all stages at 98 per cent specificity. A larger study of about 1,200 samples, known as OC2200, did not repeat that result, because the company …